Product Information

GNP ASPIRIN 325 MG TABLET is a generic product labeled by AmerisourceBergen, priced at $0.0164 per EA under NDC 46122069178. Its NADAC has been published 190 times since Jan 4, 2023.

GNP ASPIRIN 325 MG TABLET

Aspirin
$0.0164per EA
OTC

Strength

325 mg/1

Manufacturer

AmerisourceBergen

NDC

46122069178

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ASPIRIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

3/10/2021

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor

Price Statistics

The NADAC for GNP ASPIRIN 325 MG TABLET has been published 190 times since Jan 4, 2023, and over the history we have for it it has risen 49.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0164 per EA
All-time high$0.0166 (Jul 10, 2024)
All-time low$0.0110 (Jan 4, 2023)
52-week high$0.0164
52-week low$0.0154
Median price$0.0156
Average price$0.0148
Largest weekly change-18.8% (Apr 19, 2023)
Weeks tracked190
Tracking sinceJan 4, 2023

Price History

1W

+2.1%

1M

+2.1%

3M

+2.5%

6M

+5.1%

1Y

+6.9%

3Y

+41.2%

5Y

N/A

All

+49.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GNP ASPIRIN 325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GNP ASPIRIN 325 MG TABLET, manufactured by AmerisourceBergen, is $0.0164 per EA (NDC 46122069178), effective Aug 19, 2026.

How has the price of GNP ASPIRIN 325 MG TABLET changed over time?

Over the history we have for it, the NADAC for GNP ASPIRIN 325 MG TABLET has risen 49.5%. It has been tracked across 190 weekly CMS publications since Jan 4, 2023.

What are the highest and lowest recorded NADAC prices for GNP ASPIRIN 325 MG TABLET?

Since Jan 4, 2023, the NADAC for GNP ASPIRIN 325 MG TABLET has ranged from a low of $0.0110 (Jan 4, 2023) to a high of $0.0166 (Jul 10, 2024), with a median of $0.0156 per EA.

Are there cheaper alternatives to GNP ASPIRIN 325 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ASPIRIN 325 MG TABLET, is $0.0121 per EA — about 27% below GNP ASPIRIN 325 MG TABLET.

Who manufactures GNP ASPIRIN 325 MG TABLET?

GNP ASPIRIN 325 MG TABLET (NDC 46122069178) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.